NEU | Small Caps

Neuren Pharmaceuticals ASX NEU FDA grants orphan drug designation Phelan-McDermid Pitt Hopkins syndrome

Neuren Pharma granted orphan drug status for treatment of Phelan-McDermid, Pitt Hopkins and Angelman syndromes

October 16, 2019

A drug developed by Neuren Pharmaceuticals (ASX: NEU) to treat debilitating childhood neurodevelopmental disorders has been granted orphan drug designation by the US Food...

Read more

Neuren Pharmaceuticals ASX NEU NNZ-2591 Pitt Hopkins Angelman syndrome model

Neuren’s NNZ-2591 drug candidate alleviates Pitt Hopkins and Angelman syndrome symptoms

May 17, 2019

Neuren Pharmaceuticals (ASX: NEU) has revealed positive pre-clinical results for its NNZ-2591 drug candidate in treating Pitt Hopkins and Angelman syndromes. According to Neuren, its...

Read more

Neuren Pharmaceuticals ASX NEU ACADIA Pharma trofinetide Rett Syndrom licence US

Neuren Pharmaceuticals receives first payment in Rett drug licence deal

August 22, 2018

Neuren Pharmaceuticals (ASX: NEU) has received the first US$10 million payment under a recently announced licence deal with US-based ACADIA Pharmaceuticals to develop its...

Read more

Neuren Pharmaceuticals NEU Phase 3 FDA approval Rett syndrome

FDA greenlights Neuren Pharmaceuticals to kick-off next trial for Rett drug

October 13, 2017

Melbourne-based Neuren Pharmaceuticals (ASX: NEU) reported the US Food and Drug Administration has given the greenlight for the company to start phase three trials...

Read more

RECENT POSTS

Aerometrex ASX IPO AMX aerial mapping

Aerometrex cleared for takeoff on ASX following $25m IPO

December 9, 2019

$Whitebark Energy ASX WBE Wizard Lake Rex-3 frac oil$

Whitebark Energy to begin flow back at Rex-3 following frac completion

December 9, 2019

Freehill Mining ASX FHS copper mineralisation Yerbas Buenas IP anomalies Chile

Freehill Mining finds ‘strong’ copper mineralisation in Yerbas Buenas northern area

December 9, 2019

SenSen Networks ASX SNS Angel Playing Cards Japan

SenSen Networks signs SenGame 3.0 distribution deal with Japanese casino supplier

December 9, 2019

STOCK SUMMARY

INVESTOR TOOLS

HOT TOPICS

Stock market 2019 Australia ASX weekly review

Weekly review: a great year for markets despite lots of global worries

December 7, 2019

ASIC mining IPOs exploration initial public offering brokers micro cap small

ASIC calls for better handling of micro-cap mining and exploration IPOs

December 7, 2019

Back to the future economic growth low interest rates

Back to the future with sluggish economic growth and low interest rates

December 6, 2019

TRENDING POSTS

Nuchev goat milk ASX IPO NUC

Goat milk supplier Nuchev set to make ASX debut following $48.6 million IPO

ASIC mining IPOs exploration initial public offering brokers micro cap small

ASIC calls for better handling of micro-cap mining and exploration IPOs

Stock market 2019 Australia ASX weekly review

Weekly review: a great year for markets despite lots of global worries

Amaero International ASX IPO 3d printing additive manufacturing

Amaero International lists on ASX after heavily oversubscribed IPO

Legend Mining ASX LEG Rockford Nova Fraser Range nickel copper Mark Creasy

Legend Mining describes nickel discovery as ‘watershed moment’ for company and Fraser Range

Tyro Payments ASX IPO TYR eftpos

Tyro Payments to list on ASX following $287m IPO

NOVONIX Samsung SDI lithium-ion battery PUREgraphite anode ASX NVX

Novonix secures long-term supply agreement with lithium-ion battery manufacturer Samsung SDI

Macarthur Minerals IPO ASX MIO

Macarthur Minerals gives Australian investors access to advanced iron ore project with ASX debut

Small Caps is Australia's #1 site for news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.